Keywords: Contrast mechanisms: Diffusion, Body: Body, Cross-organ: Cancer
This lecture provides an overview of how diffusion MRI has been used to measure tissue microstructural properties in various tissues and organs outside the brain. We will focus on (i) diffusion microstructure models in the body that have been used to measure the tissue microstructural properties in specific examples including muscle, breast, and prostate; and (ii) diffusion microstructure models for tumor that can be used to measure cancer cell properties, such as cell size and transcytolemmal water exchange rate. The need and challenges for validation will also be discussed.1. Novikov, D.S., et al., Quantifying brain microstructure with diffusion MRI: Theory and parameter estimation. NMR Biomed, 2019. 32(4): p. e3998.
2. Fieremans, E., et al., In vivo measurement of membrane permeability and myofiber size in human muscle using time-dependent diffusion tensor imaging and the random permeable barrier model. NMR Biomed, 2017. 30(3).
3. Kim, S., et al., Dependence on diffusion time of apparent diffusion tensor of ex vivo calf tongue and heart. Magn Reson Med, 2005. 54(6): p. 1387-96.
4. Winters, K.V., et al., Quantifying myofiber integrity using diffusion MRI and random permeable barrier modeling in skeletal muscle growth and Duchenne muscular dystrophy model in mice. Magn Reson Med, 2018. 80(5): p. 2094-2108.
5. Lemberskiy, G., et al., Time-Dependent Diffusion in Prostate Cancer. Invest Radiol, 2017. 52(7): p. 405-411.
6. Teruel, J.R., et al., Stimulated echo diffusion tensor imaging (STEAM-DTI) with varying diffusion times as a probe of breast tissue. J Magn Reson Imaging, 2017. 45(1): p. 84-93.
7. Kim, S., et al., Diffusion-Weighted Magnetic Resonance Imaging for Predicting and Detecting Early Response to Chemoradiation Therapy of Squamous Cell Carcinomas of the Head and Neck. Clinical Cancer Research, 2009. 15(3): p. 986-994.
8. Thoeny, H.C. and B.D. Ross, Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging, 2010. 32(1): p. 2-16.
9. Padhani, A.R., et al., Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. Neoplasia, 2009. 11(2): p. 102-25.
10. Iima, M. and D. Le Bihan, Clinical Intravoxel Incoherent Motion and Diffusion MR Imaging: Past, Present, and Future. Radiology, 2016. 278(1): p. 13-32.
11. Jensen, J.H., et al., Diffusional kurtosis imaging: The quantification of non-Gaussian water diffusion by means of magnetic resonance imaging. Magnetic Resonance in Medicine, 2005. 53(6): p. 1432-1440.
12. Jansen, J.F., et al., Non-gaussian analysis of diffusion-weighted MR imaging in head and neck squamous cell carcinoma: A feasibility study. AJNR Am J Neuroradiol, 2010. 31(4): p. 741-8.
13. Wu, R., et al., Assessment of chemotherapy response in non-Hodgkin lymphoma involving the neck utilizing diffusion kurtosis imaging: a preliminary study. Diagn Interv Radiol, 2017. 23(3): p. 245-249.
14. Panagiotaki, E., et al., Noninvasive quantification of solid tumor microstructure using VERDICT MRI. Cancer Res, 2014. 74(7): p. 1902-12.
15. Jiang, X., et al., Quantification of cell size using temporal diffusion spectroscopy. Magn Reson Med, 2016. 75(3): p. 1076-85.
16. Reynaud, O., et al., Pulsed and oscillating gradient MRI for assessment of cell size and extracellular space (POMACE) in mouse gliomas. NMR Biomed, 2016. 29(10): p. 1350-63.
17. Solomon, E., et al., Time-dependent diffusivity and kurtosis in phantoms and patients with head and neck cancer. Magn Reson Med, 2023. 89(2): p. 522-535.